Загрузка...
MicroRNA-92b augments sorafenib resistance in hepatocellular carcinoma via targeting PTEN to activate PI3K/AKT/mTOR signaling
Sorafenib (SOR) resistance is still a significant challenge for the effective treatment of hepatocellular carcinoma (HCC). The mechanism of sorafenib resistance remains unclear. Several microRNAs (miRNAs) have been identified as playing a role in impairing the sensitivity of tumor cells to treatment...
Сохранить в:
| Опубликовано в: : | Braz J Med Biol Res |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Associação Brasileira de Divulgação Científica
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8186377/ https://ncbi.nlm.nih.gov/pubmed/34076140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1414-431X2020e10390 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|